TRVI
Trevi Therapeutics, Inc.
Company overview
- Market capitalization
- $2.05B
- Employees
- 34
- Latest publication
- 2026-09-29
About Trevi Therapeutics, Inc.
Trevi Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops and commercializes investigational therapy for the treatment of chronic cough in patients with idiopathic pulmonary fibrosis (IPF) and non-IPF interstitial lung disease, and refractory chronic cough. The company develops Haduvio, an oral extended-release formulation of nalbuphine, which is in phase 2b Cough Reduction in IPF with nalbuphine ER clinical trial for treatment of chronic cough in patients with IPF, and phase 2a clinical trial in patients with refractory chronic cough. Trevi Therapeutics, Inc. has a license agreement with Keenova Therapeutics plc to develop and commercialize products incorporating nalbuphine hydrochloride in various formulations. Trevi Therapeutics, Inc. was incorporated in 2011 and is headquartered in New Haven, Connecticut.
Financial statements
Income Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0USD | 0USD | 0USD | 0USD | 0USD | 146,000USD | 0USD | 0USD |
| Cost Of Revenue | 34,000USD | 31,000USD | — | 38,000USD | 37,000USD | 38,000USD | 36,000USD | 38,000USD |
| Gross Profit | -34,000USD | -31,000USD | — | -38,000USD | -37,000USD | -38,000USD | -36,000USD | -38,000USD |
| Research Development | 9,941,000USD | 6,193,000USD | 10,085,000USD | 9,389,000USD | 7,811,000USD | 9,328,000USD | 11,224,000USD | 10,021,000USD |
| Selling General Administrative | 4,971,000USD | 4,027,000USD | 3,831,000USD | 4,333,000USD | 3,659,000USD | 2,915,000USD | 2,863,000USD | 3,268,000USD |
| Total Operating Expenses | 14,912,000USD | 10,220,000USD | 13,916,000USD | 13,722,000USD | 11,470,000USD | 12,205,000USD | 14,087,000USD | 13,251,000USD |
| Operating Income | -14,912,000USD | -10,220,000USD | -13,916,000USD | -13,722,000USD | -11,470,000USD | -12,243,000USD | -14,087,000USD | -13,289,000USD |
| Interest Income | 1,696,000USD | 1,903,000USD | 2,101,000USD | 1,407,000USD | 1,125,000USD | 843,000USD | 826,000USD | 935,000USD |
| Net Interest Income | 1,696,000USD | 1,903,000USD | 2,101,000USD | 1,407,000USD | 1,125,000USD | 842,000USD | 825,000USD | 934,000USD |
| Income Before Tax | -13,212,000USD | -8,332,000USD | -11,817,000USD | -12,322,000USD | -10,351,000USD | -11,399,000USD | -13,273,000USD | -12,360,000USD |
| Income Tax Expense | -20,000USD | -16,000USD | -15,000USD | -21,000USD | -11,000USD | 16,000USD | -31,000USD | -8,000USD |
| Tax Provision | -20,000USD | -16,000USD | -15,000USD | -21,000USD | -11,000USD | 16,000USD | -31,000USD | -8,000USD |
| Net Income | -13,192,000USD | -8,316,000USD | -11,802,000USD | -12,301,000USD | -10,340,000USD | -11,415,000USD | -13,242,000USD | -12,352,000USD |
| Net Income From Continuing Ops | -13,192,000USD | -8,316,000USD | -11,802,000USD | -12,301,000USD | -10,340,000USD | -11,415,000USD | -13,242,000USD | -12,352,000USD |
| Ebit | -13,212,000USD | -8,332,000USD | -11,817,000USD | -12,322,000USD | -10,351,000USD | -11,398,000USD | -13,272,000USD | -12,359,000USD |
| Ebitda | -13,178,000USD | -8,301,000USD | -11,779,000USD | -12,284,000USD | -10,314,000USD | -11,360,000USD | -13,236,000USD | -12,321,000USD |
| Depreciation And Amortization | 34,000USD | 31,000USD | 38,000USD | 38,000USD | 37,000USD | 38,000USD | 36,000USD | 38,000USD |
| Reconciled Depreciation | 34,000USD | 31,000USD | 38,000USD | 38,000USD | 37,000USD | 38,000USD | 36,000USD | 38,000USD |
| Total Other Income Expense Net | 1,700,000USD | 1,888,000USD | 2,099,000USD | 1,400,000USD | 1,119,000USD | 844,000USD | 814,000USD | 929,000USD |
| Interest Expense | — | 0USD | 0USD | 0USD | 0USD | 1,000USD | 1,000USD | 1,000USD |
| Selling And Marketing Expenses | — | — | — | — | — | — | — | 38,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD |
| Cost Of Revenue | 132,000USD | 147,000USD | 123,000USD | 43,000USD | 50,000USD | 47,000USD | 39,000USD | 23,000USD |
| Gross Profit | -132,000USD | -147,000USD | -123,000USD | -43,000USD | -50,000USD | -47,000USD | -39,000USD | -23,000USD |
| Research Development | 33,478,000USD | 39,377,000USD | 23,683,000USD | 19,834,000USD | 22,984,000USD | 22,328,000USD | 19,339,000USD | 14,072,000USD |
| Selling General Administrative | 15,850,000USD | 12,147,000USD | 10,240,000USD | 10,073,000USD | 9,492,000USD | 10,161,000USD | 7,306,000USD | 4,336,000USD |
| Total Operating Expenses | 49,328,000USD | 51,524,000USD | 33,923,000USD | 29,907,000USD | 32,476,000USD | 32,489,000USD | 26,645,000USD | 18,408,000USD |
| Operating Income | -49,328,000USD | -51,524,000USD | -33,923,000USD | -29,907,000USD | -32,476,000USD | -32,489,000USD | -26,645,000USD | -18,408,000USD |
| Interest Income | 6,536,000USD | 3,602,000USD | 4,728,000USD | 1,740,000USD | 10,000USD | 178,000USD | 792,000USD | 156,000USD |
| Interest Expense | 0USD | 4,000USD | 391,000USD | 780,000USD | 1,202,000USD | 456,000USD | 616,000USD | 174,000USD |
| Net Interest Income | 6,536,000USD | 3,598,000USD | 4,067,000USD | 577,000USD | -1,192,000USD | -278,000USD | 792,000USD | -18,000USD |
| Income Before Tax | -42,823,000USD | -47,941,000USD | -29,097,000USD | -29,188,000USD | -33,961,000USD | -32,776,000USD | -26,068,000USD | -20,669,000USD |
| Income Tax Expense | -64,000USD | -30,000USD | -32,000USD | -36,000USD | -21,000USD | -18,000USD | -18,000USD | -124,000USD |
| Tax Provision | -64,000USD | -30,000USD | -70,000USD | -36,000USD | -21,000USD | -18,000USD | -18,000USD | -124,000USD |
| Net Income | -42,759,000USD | -47,911,000USD | -29,065,000USD | -29,152,000USD | -33,940,000USD | -32,758,000USD | -26,050,000USD | -20,545,000USD |
| Net Income From Continuing Ops | -42,759,000USD | -47,911,000USD | -26,749,000USD | -29,152,000USD | -33,940,000USD | -32,758,000USD | -26,050,000USD | -20,545,000USD |
| Ebit | -42,823,000USD | -47,937,000USD | -28,706,000USD | -29,907,000USD | -32,759,000USD | -32,489,000USD | -26,645,000USD | -18,408,000USD |
| Ebitda | -42,679,000USD | -47,790,000USD | -28,583,000USD | -29,864,000USD | -32,709,000USD | -32,442,000USD | -26,606,000USD | -18,385,000USD |
| Depreciation And Amortization | 144,000USD | 147,000USD | 123,000USD | 43,000USD | 50,000USD | 47,000USD | 39,000USD | 23,000USD |
| Reconciled Depreciation | 144,000USD | 147,000USD | 103,000USD | 43,000USD | 50,000USD | 47,000USD | 39,000USD | 23,000USD |
| Total Other Income Expense Net | 6,505,000USD | 3,583,000USD | 4,826,000USD | 719,000USD | -1,485,000USD | -287,000USD | 577,000USD | -2,261,000USD |
| Selling And Marketing Expenses | — | — | 287,000USD | — | — | — | — | — |
| Non Operating Income Net Other | — | — | — | 142,000USD | — | -9,000USD | — | — |
| Net Income Applicable To Common Shares | — | — | — | -29,152,000USD | -33,940,000USD | -32,758,000USD | -26,754,000USD | -25,577,000USD |
| Minority Interest | — | — | — | — | — | — | — | 0USD |
| Discontinued Operations | — | — | — | — | — | — | — | 0USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 330,518,000USD | 179,606,000USD | 193,439,000USD | 199,356,000USD | 208,339,000USD | 107,004,000USD | 110,900,000USD | 68,908,000USD |
| Cash And Equivalents | 54,302,000USD | — | — | — | — | — | — | — |
| Cash And Short Term Investments | 318,870,000USD | 171,783,000USD | 188,260,000USD | 194,927,000USD | 203,885,000USD | 103,257,000USD | 107,622,000USD | 65,493,000USD |
| Short Term Investments | 264,568,000USD | 152,371,000USD | 169,346,000USD | 138,058,000USD | 86,827,000USD | 83,883,000USD | 73,525,000USD | 49,441,000USD |
| Total Current Assets | 325,705,000USD | 176,121,000USD | 191,656,000USD | 198,299,000USD | 207,228,000USD | 105,621,000USD | 109,428,000USD | 67,336,000USD |
| Other Current Assets | 2,572,000USD | 4,338,000USD | 2,410,000USD | 3,372,000USD | 3,343,000USD | 2,364,000USD | 1,274,000USD | 1,843,000USD |
| Other Non Current Assets | 3,935,000USD | — | — | — | — | — | — | — |
| Total Liabilities | 9,012,000USD | — | — | — | — | — | — | — |
| Total Current Liabilities | 8,736,000USD | 7,115,000USD | 9,749,000USD | 9,041,000USD | 9,241,000USD | 6,866,000USD | 10,509,000USD | 9,123,000USD |
| Other Current Liabilities | 5,309,000USD | — | — | — | — | — | — | — |
| Total Stockholder Equity | 321,506,000USD | 172,127,000USD | 183,244,000USD | 189,788,000USD | 198,493,000USD | 99,457,000USD | 99,644,000USD | 58,969,000USD |
| Total Equity Including Noncontrolling Interest | 321,506,000USD | — | — | — | — | — | — | — |
| Property Plant Equipment Net | 878,000USD | 875,000USD | 855,000USD | 954,000USD | 1,043,000USD | 1,142,000USD | 1,229,000USD | 1,316,000USD |
| Accounts Payable | 3,098,000USD | 2,215,000USD | 3,911,000USD | 2,709,000USD | 2,974,000USD | 1,421,000USD | 3,414,000USD | 1,614,000USD |
| Short Term Debt | 329,000USD | 318,000USD | 307,000USD | 296,000USD | 286,000USD | 276,000USD | 285,000USD | 297,000USD |
| Common Stock | 142,000USD | 128,000USD | 128,000USD | 128,000USD | 122,000USD | 100,000USD | 94,000USD | 75,000USD |
| Retained Earnings | -360,793,000USD | -342,996,000USD | -329,804,000USD | -321,488,000USD | -309,686,000USD | -297,385,000USD | -287,045,000USD | -275,630,000USD |
| Accumulated Other Comprehensive Income | -425,000USD | -190,000USD | 148,000USD | 30,000USD | 24,000USD | 73,000USD | 61,000USD | 139,000USD |
| Total Liab | — | 7,479,000USD | 10,195,000USD | 9,568,000USD | 9,846,000USD | 7,547,000USD | 11,256,000USD | 9,939,000USD |
| Other Current Liab | — | 4,582,000USD | 5,531,000USD | 6,036,000USD | 5,981,000USD | 5,169,000USD | 6,810,000USD | 7,212,000USD |
| Capital Stock | — | 128,000USD | 128,000USD | 128,000USD | 122,000USD | 100,000USD | 94,000USD | 75,000USD |
| Cash | — | 19,412,000USD | 18,914,000USD | 56,869,000USD | 117,058,000USD | 19,374,000USD | 34,097,000USD | 16,052,000USD |
| Net Debt | — | -18,730,000USD | -18,161,000USD | -56,046,000USD | -116,167,000USD | -18,417,000USD | -33,065,000USD | -14,939,000USD |
| Short Long Term Debt Total | — | 682,000USD | 753,000USD | 823,000USD | 891,000USD | 957,000USD | 1,032,000USD | 1,113,000USD |
| Property Plant Equipment Gross | — | 875,000USD | 1,214,000USD | 954,000USD | 1,043,000USD | 1,142,000USD | 1,457,000USD | 1,316,000USD |
| Common Stock Shares Outstanding | — | 145,592,901shares | 145,502,344shares | 145,104,986shares | 130,350,391shares | 117,610,750shares | 106,009,686shares | 101,041,573shares |
| Non Current Assets Total | — | 3,485,000USD | 1,783,000USD | 1,057,000USD | 1,111,000USD | 1,383,000USD | 1,472,000USD | 1,572,000USD |
| Non Current Liabilities Total | — | 364,000USD | 446,000USD | 527,000USD | 605,000USD | 681,000USD | 747,000USD | 816,000USD |
| Non Currrent Assets Other | — | 2,610,000USD | 928,000USD | 103,000USD | 68,000USD | 241,000USD | 243,000USD | 256,000USD |
| Net Working Capital | — | 169,006,000USD | 181,907,000USD | 189,258,000USD | 197,987,000USD | 98,755,000USD | 98,919,000USD | 58,213,000USD |
| Unclassified Equity | — | 515,057,000USD | 512,644,000USD | 510,990,000USD | 507,911,000USD | 396,569,000USD | 386,440,000USD | 334,310,000USD |
| Net Receivables | — | — | 986,000USD | — | — | — | 532,000USD | — |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 193,439,000USD | 110,900,000USD | 89,403,000USD | 123,015,000USD | 38,475,000USD | 47,131,000USD | 60,001,000USD | 20,489,000USD |
| Other Current Assets | 2,410,000USD | 1,274,000USD | 4,576,000USD | 2,106,000USD | 886,000USD | 108,000USD | 1,681,000USD | 1,438,000USD |
| Total Liab | 10,195,000USD | 11,256,000USD | 6,856,000USD | 15,556,000USD | 21,400,000USD | 19,849,000USD | 5,456,000USD | 3,182,000USD |
| Total Stockholder Equity | 183,244,000USD | 99,644,000USD | 82,547,000USD | 107,459,000USD | 17,075,000USD | 27,282,000USD | 54,545,000USD | 17,307,000USD |
| Other Current Liab | 5,531,000USD | 6,810,000USD | 3,709,000USD | 3,518,000USD | 3,922,000USD | 3,426,000USD | 3,501,000USD | 2,073,000USD |
| Common Stock | 128,000USD | 94,000USD | 68,000USD | 60,000USD | 29,000USD | 19,000USD | 18,000USD | 101,000USD |
| Capital Stock | 128,000USD | 94,000USD | 68,000USD | 60,000USD | 29,000USD | 19,000USD | 18,000USD | 101,000USD |
| Retained Earnings | -329,804,000USD | -287,045,000USD | -239,134,000USD | -210,069,000USD | -180,917,000USD | -146,977,000USD | -114,219,000USD | -109,498,000USD |
| Cash | 18,914,000USD | 34,097,000USD | 32,397,000USD | 12,589,000USD | 36,830,000USD | 45,001,000USD | 57,313,000USD | 17,165,000USD |
| Cash And Short Term Investments | 188,260,000USD | 107,622,000USD | 82,971,000USD | 120,510,000USD | 36,830,000USD | 45,001,000USD | 57,313,000USD | 17,165,000USD |
| Total Current Assets | 191,656,000USD | 109,428,000USD | 87,547,000USD | 122,616,000USD | 37,957,000USD | 46,269,000USD | 59,552,000USD | 18,787,000USD |
| Total Current Liabilities | 9,749,000USD | 10,509,000USD | 5,824,000USD | 13,400,000USD | 12,724,000USD | 5,555,000USD | 5,199,000USD | 2,676,000USD |
| Net Debt | -18,161,000USD | -33,065,000USD | -31,059,000USD | -3,411,000USD | -22,201,000USD | -30,790,000USD | -56,957,000USD | -16,069,000USD |
| Short Term Debt | 307,000USD | 285,000USD | 306,000USD | 7,025,000USD | 5,953,000USD | 113,000USD | 99,000USD | 0USD |
| Short Long Term Debt Total | 753,000USD | 1,032,000USD | 1,338,000USD | 9,178,000USD | 14,629,000USD | 14,263,000USD | 356,000USD | 1,096,000USD |
| Short Term Investments | 169,346,000USD | 73,525,000USD | 50,574,000USD | 107,921,000USD | 0USD | — | — | 0USD |
| Net Receivables | 986,000USD | 532,000USD | — | — | 241,000USD | 265,000USD | 558,000USD | 184,000USD |
| Accounts Payable | 3,911,000USD | 3,414,000USD | 1,809,000USD | 2,857,000USD | 2,849,000USD | 2,016,000USD | 1,599,000USD | 603,000USD |
| Property Plant Equipment Net | 855,000USD | 1,229,000USD | 1,559,000USD | 194,000USD | 184,000USD | 330,000USD | 430,000USD | 149,000USD |
| Property Plant Equipment Gross | 1,214,000USD | 1,457,000USD | 1,693,000USD | 419,000USD | 366,000USD | 330,000USD | 430,000USD | 149,000USD |
| Accumulated Other Comprehensive Income | 148,000USD | 61,000USD | -29,000USD | -122,000USD | — | — | -60,001,000USD | -46,000USD |
| Common Stock Shares Outstanding | 145,104,986shares | 101,041,573shares | 99,033,373shares | 64,541,911shares | 22,841,481shares | 18,059,011shares | 17,834,570shares | 8,965,247shares |
| Non Current Assets Total | 1,783,000USD | 1,472,000USD | 1,856,000USD | 399,000USD | 518,000USD | 862,000USD | 449,000USD | 1,702,000USD |
| Non Current Liabilities Total | 446,000USD | 747,000USD | 1,032,000USD | 2,156,000USD | 8,676,000USD | 14,294,000USD | 257,000USD | 506,000USD |
| Non Currrent Assets Other | 928,000USD | 243,000USD | 297,000USD | 205,000USD | 334,000USD | 532,000USD | 19,000USD | 1,553,000USD |
| Net Working Capital | 181,907,000USD | 98,919,000USD | 81,723,000USD | 109,216,000USD | 25,233,000USD | 40,714,000USD | 54,353,000USD | 16,111,000USD |
| Unclassified Equity | 512,644,000USD | 386,440,000USD | 321,574,000USD | 317,530,000USD | 197,934,000USD | 174,221,000USD | 228,729,000USD | 126,649,000USD |
| Other Assets | — | — | 0USD | 205,000USD | 334,000USD | 759USD | 19,000USD | 1,553,000USD |
| Unclassified Non Current Liabilities | — | — | 1,032,000USD | — | — | — | — | -3,044,000USD |
| Other Liab | — | — | — | 3,000USD | — | 196,000USD | — | 460,000USD |
| Short Long Term Debt | — | — | — | 7,000,000USD | 5,833,000USD | — | — | 0USD |
| Long Term Debt | — | — | — | 2,151,000USD | 8,652,000USD | 13,954,000USD | — | 1,096,000USD |
| Non Current Liabilities Other | — | — | — | 5,000USD | — | — | — | 460,000USD |
| Net Tangible Assets | — | — | — | 107,459,000USD | 17,075,000USD | 27,282,000USD | 54,545,000USD | -109,494,000USD |
| Unclassified Current Liabilities | — | — | — | -7,000,000USD | -9,641,000USD | — | — | — |
| Current Deferred Revenue | — | — | — | — | 3,808,000USD | — | — | — |
| Inventory | — | — | — | — | -241,000USD | 895,000USD | 1,604,000USD | 1,396,000USD |
| Deferred Long Term Liab | — | — | — | — | — | 284,000USD | — | 1,534,000USD |
| Unclassified Current Assets | — | — | — | — | — | — | -1,604,000USD | -1,396,000USD |
| Intangible Assets | — | — | — | — | — | — | — | 0USD |
| Good Will | — | — | — | — | — | — | — | 0USD |
| Long Term Investments | — | — | — | — | — | — | — | 0USD |
| Additional Paid In Capital | — | — | — | — | — | — | — | 0USD |
| Treasury Stock | — | — | — | — | — | — | — | 0USD |
| Unclassified Non Current Assets | — | — | — | — | — | — | — | -1,553,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -13,192,000USD | -8,316,000USD | -11,802,000USD | -12,301,000USD | -10,340,000USD | -11,415,000USD | -13,242,000USD | -12,352,000USD |
| Depreciation | 34,000USD | 31,000USD | 38,000USD | 38,000USD | 37,000USD | 38,000USD | 36,000USD | 38,000USD |
| Stock Based Compensation | 2,191,000USD | 1,350,000USD | 1,243,000USD | 1,384,000USD | 1,208,000USD | 917,000USD | 821,000USD | 1,127,000USD |
| Other Non Cash Items | -326,000USD | -422,000USD | -190,000USD | -273,000USD | -283,000USD | -99,000USD | -324,000USD | -223,000USD |
| Change In Working Capital | -5,396,000USD | -274,000USD | -169,000USD | 1,051,000USD | -4,099,000USD | 1,009,000USD | 3,153,000USD | 2,727,000USD |
| Total Cash From Operating Activities | -16,689,000USD | -7,631,000USD | -10,880,000USD | -10,101,000USD | -13,477,000USD | -9,550,000USD | -9,556,000USD | -8,683,000USD |
| Capital Expenditures | -102,000USD | 13,477,000USD | -12,000USD | 0USD | -13,477,000USD | -7,000USD | 0USD | -28,000USD |
| Free Cash Flow | -16,791,000USD | 5,846,000USD | -10,892,000USD | -10,101,000USD | -13,477,000USD | -9,557,000USD | -9,556,000USD | -8,711,000USD |
| Investments | 17,067,000USD | -30,608,000USD | -50,938,000USD | -2,610,000USD | -9,951,000USD | -23,872,000USD | 7,667,000USD | 2,768,000USD |
| Total Cashflows From Investing Activities | 16,965,000USD | -30,608,000USD | -50,938,000USD | -2,610,000USD | -9,951,000USD | -23,872,000USD | 7,667,000USD | 2,768,000USD |
| Net Borrowings | 0USD | 0USD | 0USD | 0USD | -11,000USD | -31,000USD | -32,000USD | — |
| Total Cash From Financing Activities | 222,000USD | 284,000USD | 1,629,000USD | 110,395,000USD | 8,705,000USD | 51,467,000USD | 4,978,000USD | 5,067,000USD |
| Change In Cash | 498,000USD | -37,955,000USD | -60,189,000USD | 97,684,000USD | -14,723,000USD | 18,045,000USD | 3,089,000USD | -848,000USD |
| Begin Period Cash Flow | 18,914,000USD | 56,869,000USD | 117,058,000USD | 19,374,000USD | 34,097,000USD | 16,052,000USD | 12,963,000USD | 13,811,000USD |
| End Period Cash Flow | 19,412,000USD | 18,914,000USD | 56,869,000USD | 117,058,000USD | 19,374,000USD | 34,097,000USD | 16,052,000USD | 12,963,000USD |
| Other Cashflows From Investing Activities | 431,000USD | 167,000USD | 693,000USD | 383,000USD | 395,000USD | — | 1,070,000USD | 2,796USD |
| Other Cashflows From Financing Activities | 222,000USD | 725,000USD | 506,000USD | 107,786,000USD | -222,000USD | 49,000USD | 163,000USD | 4,850,000USD |
| Issuance Of Capital Stock | — | 0USD | 0USD | — | — | 51,449,000USD | 4,847,000USD | — |
| Unclassified Investing Cash Flow | — | -13,644,000USD | — | — | 13,082,000USD | — | -1,070,000USD | — |
| Unclassified Financing Cash Flow | — | — | 1,123,000USD | 2,609,000USD | 8,938,000USD | — | — | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -42,759,000USD | -47,911,000USD | -29,065,000USD | -29,152,000USD | -33,940,000USD | -32,758,000USD | -26,050,000USD | -20,545,000USD |
| Depreciation | 144,000USD | 147,000USD | 123,000USD | 43,000USD | 50,000USD | 47,000USD | 39,000USD | 23,000USD |
| Stock Based Compensation | 5,185,000USD | 3,588,000USD | 2,247,000USD | 2,327,000USD | 2,543,000USD | 2,417,000USD | 1,127,000USD | 496,000USD |
| Other Non Cash Items | -1,168,000USD | -907,000USD | -1,168,000USD | -162,000USD | 974,000USD | 236,000USD | 215,000USD | 2,303,000USD |
| Change In Working Capital | -3,491,000USD | 6,827,000USD | -3,847,000USD | -1,231,000USD | 1,509,000USD | 1,058,000USD | 1,576,000USD | -568,000USD |
| Total Cash From Operating Activities | -42,089,000USD | -38,256,000USD | -31,710,000USD | -28,175,000USD | -28,946,000USD | -29,000,000USD | -23,093,000USD | -18,291,000USD |
| Capital Expenditures | -12,000USD | -35,000USD | -137,000USD | -159,000USD | -159,000USD | -32,000USD | -9,000USD | -158,000USD |
| Free Cash Flow | -42,101,000USD | -38,291,000USD | -31,847,000USD | -28,334,000USD | -28,946,000USD | -29,032,000USD | -23,102,000USD | -18,449,000USD |
| Investments | -94,095,000USD | -21,528,000USD | -1,723,000USD | -126,215,000USD | -107,214,000USD | -32,000USD | -9,000USD | -158,000USD |
| Total Cashflows From Investing Activities | -94,107,000USD | -21,528,000USD | 59,428,000USD | -107,373,000USD | -107,373,000USD | -32,000USD | -9,000USD | -158,000USD |
| Net Borrowings | -11,000USD | -126,000USD | -9,504,000USD | -5,854,000USD | -5,833,000USD | 14,000,000USD | 14,000,000USD | -4,813,000USD |
| Total Cash From Financing Activities | 121,013,000USD | 61,484,000USD | -7,910,000USD | 111,307,000USD | 20,775,000USD | 16,720,000USD | 73,213,000USD | 3,629USD |
| Issuance Of Capital Stock | 108,154,000USD | 61,146,000USD | 4,110,000USD | 105,410,000USD | 21,183,000USD | 3,135,000USD | 75,063,000USD | 10,496,000USD |
| Change In Cash | -15,183,000USD | 1,700,000USD | 19,808,000USD | -24,241,000USD | -8,171,000USD | -12,312,000USD | 50,111,000USD | -14,818,000USD |
| Begin Period Cash Flow | 34,097,000USD | 32,397,000USD | 12,589,000USD | 36,830,000USD | 45,001,000USD | 57,313,000USD | 7,202,000USD | 22,020,000USD |
| End Period Cash Flow | 18,914,000USD | 34,097,000USD | 32,397,000USD | 12,589,000USD | 36,830,000USD | 45,001,000USD | 57,313,000USD | 7,202,000USD |
| Other Cashflows From Investing Activities | 1,638,000USD | 1,367,000USD | — | 829,000USD | — | -32,000USD | -9,000USD | 0USD |
| Other Cashflows From Financing Activities | 714,000USD | 464,000USD | -211,000USD | 11,730,000USD | -340,000USD | -415,000USD | 13,804,000USD | 9,976,000USD |
| Unclassified Investing Cash Flow | -1,638,000USD | -1,332,000USD | 61,288,000USD | 18,172,000USD | — | — | — | — |
| Unclassified Financing Cash Flow | 12,156,000USD | — | -2,305,000USD | -11,730,000USD | 5,765,000USD | 3,466,000USD | 48,861,000USD | -3,625,371USD |
| Change To Liabilities | — | — | — | -630,000USD | 831,000USD | 417,000USD | 777,000USD | 66,000USD |
| Sale Purchase Of Stock | — | — | — | 117,161,000USD | — | -331,000USD | -1,213,000USD | -1,534,000USD |
| Cash And Cash Equivalents Changes | — | — | — | -24,241,000USD | — | -12,312,000USD | — | — |
| Change To Account Receivables | — | — | — | — | — | 293,000USD | -374,000USD | -135,000USD |
| Change To Inventory | — | — | — | — | — | -293,000USD | 374,000USD | 0USD |
| Dividends Paid | — | — | — | — | — | — | -2,239,000USD | 0USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
No revenue breakdown is currently published for this company.
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.